Predicting Hepatotoxicity with CellCiphr HCS technology: Rat and Human Hepatotoxicity Predicton: Validation and Case Studies
Katya Tsaioun, CSO, Cyprotex speaking at ADMET Europe 2011
Metabolomics Platform for Toxicology Research in Zebrafish
Elwin Verheij, TNO, speaking at European Biomarkers Summit 2010.
A Novel Strategy for Bespoke Tissue-Specific Biomarkers for Drug Development
Gary Coulton, Director, University of London, speaking at European Biomarkers Summit 2010.
Dried Blood Spot Samples for ADME, Biomarker Analysis and Metabolomics
Elwin Verheij, Innovation Manager, TNO, speaking at ADMET Europe
Predicting the Kinetics of Drugs in the Brain
Simon Thomas, Head of Scientific Computing, Cyprotex Discovery Ltd, speaking at ADMET Europe
A Project Driven Approach to Efficient Generation of QSAR Models
Adrian Stevens, Lead Scientist, Accelrys, speaking at ADMET Europe
In Silico Methods for ADMET and Solubility Prediction
John Mitchell, Group Leader, University of St-Andrews, speaking at ADMET Europe
Metabonomics – Recent Advances in Multivariate Methods and some Results Relating to Diabetes
Richard Barton, Professor, Imperial College London, speaking at ADMET Europe
Drug-Drug Interactions Involving non-CYP Phase I or Phase II Enzymes can we Predict?
Olivier Barberan, Director of Product Development, Aureus Pharma, speaking at ADMET Europe